Variability and Risk Factors for Kidney Disease Progression and Death Following Attainment of Stage 4 CKD in a Referred Cohort

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

Andrew S. Levey, Josef Coresh, Kline Bolton et al. · Data Archiving and Networked Services (DANS) · 2002 · 11.7K citations

Medicine, Nephrology, Hemodialysis +13

Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization

Alan S. Go, Glenn M. Chertow, Dongjie Fan et al. · New England Journal of Medicine · 2004 · 11.4K citations · Full text

Medicine, Internal Medicine, Nephrology +14

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +16

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

Saulo Klahr, Andrew S. Levey, Gerald J. Beck et al. · New England Journal of Medicine · 1994 · 2.4K citations · Full text

Agriculture, Nephrology, Nutritional Sciences +17